Ciclosporine

also known as ciclosporine A · CsA · cyclosporine A

today NCT00159159 · Ph 4

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT00159159	Mar 2004 → ?	—	Hospices Civils de Lyon	Unknown	No outcome recorded

Also used as a comparator or background therapy in 2 trials

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 21 trial
Phase 2	NCT01135641 Background	Jun 2010 → Mar 2014	chronic graft versus host disease	Nantes University Hospital	Completed	No outcome recorded
Phase 31 trial
Phase 3	NCT00133887 Comparator	Apr 2004 → Mar 2011	skin cancer	Hospices Civils de Lyon	Completed	No outcome recorded

Every value below carries the sentence it was read from. 4 sources stand behind the page.

Field	Value	Cited text
Known as	ciclosporine	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00133887 ↗ 2 NCT01135641 ↗ NCT00159159 ↗
Known as	ciclosporine A	“Patients will receive in addition to ciclosporine A and corticosteroids (prednisone) 1 mg/kg/day, Rituximab at 375 mg/m²/infusion once a week for 4 consecutive weeks.” NCT01135641 ↗
Known as	CsA	“corticosteroids (CSs) and cyclosporine A (CsA) as first-line therapy for newly diagnosed cGVHD after allo-SCT.” PMID 28864814 ↗ Sep 2017
Known as	cyclosporine A	“corticosteroids (CSs) and cyclosporine A (CsA) as first-line therapy for newly diagnosed cGVHD after allo-SCT.” PMID 28864814 ↗ Sep 2017